11/15
09:32 am
orgo
Organogenesis Commends Final LCDs [Yahoo! Finance]
Medium
Report
Organogenesis Commends Final LCDs [Yahoo! Finance]
11/15
09:25 am
orgo
Organogenesis Commends Final LCDs
Medium
Report
Organogenesis Commends Final LCDs
11/13
02:32 am
orgo
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
High
Report
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
11/12
09:56 pm
orgo
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/12
04:05 pm
orgo
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
High
Report
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
11/12
04:01 pm
orgo
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
High
Report
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
11/11
05:09 pm
orgo
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Yahoo! Finance]
Low
Report
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Yahoo! Finance]
11/11
05:05 pm
orgo
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Low
Report
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
11/4
07:23 pm
orgo
Organogenesis Holdings And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
Medium
Report
Organogenesis Holdings And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
10/16
07:30 am
orgo
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
Low
Report
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
10/1
04:05 pm
orgo
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
Low
Report
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
9/4
04:05 pm
orgo
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
Low
Report
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September